Drug diversion: An investigator's perspective — part 2

Our previous webinar included insights and accounts of firsthand experiences investigating and managing drug diversion programs. Part 2 provides another in-depth discussion with John Burke, International Health Facility Diversion Association executive director. This time, we examined critical risks (for example, control design deficiencies), investigation steps and interview tactics, and lessons from real-life diversion use cases in the areas of anesthesia, nursing, and pharmacy.